Digital Health Ventures That Flew Too Close To The Sun
1.5 billion: that’s the number, in dollars, Forbes put for Proteus’ valuation last year. Dubbed as a healthcare unicorn, the startup even raised over $500 million in venture capital. It made headlines for developing the first-ever FDA-approved digital pill, one equipped with an ingestible and trackable sensor to monitor treatment compliance.  Researchers even proved the technology’s worth. In 2019, an independent study investigated the Proteus’ digital pill. They found it to be accurate, and even improved adherence of tuberculosis patients using oral pills equipped with Proteus’ s...
Source: The Medical Futurist - July 7, 2020 Category: Information Technology Authors: Prans Tags: Artificial Intelligence Future of Medicine Future of Pharma Genomics AI cancer IBM google deepmind theranos Watson fail digital pill proteus deus ex machina tech giants finances otsuka Nightingale Source Type: blogs

Top 25 Psychiatric Medications for 2018
Psychiatric medications are an important part of treatment for many people with mental disorders, such as depression, bipolar disorder, ADHD, schizophrenia, anxiety, and others. They play an important role in helping to alleviate the most serious symptoms, allowing people to better focus on their lives and on other treatment types, such as psychotherapy. Psychiatric medications are an important part of many people’s treatment plans for obtaining the most effective treatment for a mental health concern or mental illness. It’s good to know what drugs are being prescribed most often for mental disorders in the U.S...
Source: World of Psychology - December 15, 2019 Category: Psychiatry & Psychology Authors: John M. Grohol, Psy.D. Tags: General Medications Psychiatry psychiatric meds psychiatric prescriptions Source Type: blogs

Company ’s Struggles Point Out Roadblocks to Digital Therapeutics Progress
Digital therapeutics — therapeutic interventions driven by software rather than pharmaceuticals – have been on pharma’s viewscreen for quite some time. It’s not hard to see the appeal of such technologies, which stand to meet the objectives of many groups within healthcare. For the pharmas, digital therapeutics offer a new product option well-suited to an […] (Source: EMR and HIPAA)
Source: EMR and HIPAA - December 12, 2019 Category: Information Technology Authors: Anne Zieger Tags: C-Suite Leadership Clinical EMR-EHR Genomics-Precision Medicine Healthcare IT Hospital - Health System Telemedicine and Remote Monitoring Abilify Mycite Digital Therapeutics Medication Compliance Novartis Otsuka Pear Therapeutics Source Type: blogs

The Curse of Delusional Parasitosis
​Delusional parasitosis is a rare condition, but it is more common where methamphetamine and cocaine abuse is high. It is a fascinating condition to witness; patients are convinced that their skin is infested with foreign organisms or materials despite incontrovertible evidence to the contrary.This condition is known by numerous names—Ekbom syndrome, delusory parasitosis, psychogenic parasitosis, delusional parasitosis, delusional ectoparasitosis, formication, chronic tactile hallucinosis, dermatophobia, parasitophobia, and cocaine bugs—but delusional parasitosis and more recently delusional infestation are c...
Source: M2E Too! Mellick's Multimedia EduBlog - September 30, 2018 Category: Emergency Medicine Tags: Blog Posts Source Type: blogs

Trial, Meet Error: The Story of a Pharmacy Regular
“Why isn’t this medication working?” me in 2002. “Why isn’t this medication working?” me in 2018. When the university nurse first prodded me to consider medication, I hesitated before eventually relenting. My reasoning: While this little white pill may not be my salvation, it surely can’t hurt. Or can it? Over the past 16 years, my medication history is longer than a typical Catholic wedding. A is for Abilify, B is for Buspar, C is for Clonazepam…and, well, you get the idea. Medication, I naively hoped, would be a cure-all — a foolproof remedy for intrusive, tor...
Source: World of Psychology - September 22, 2018 Category: Psychiatry & Psychology Authors: Matthew Loeb Tags: Antidepressant Anxiety and Panic Depression Medications Personal Source Type: blogs

What's Caught My Attention Lately....
It's been just about a month since I last posted here, and what a month it's been.  I was away for a couple of weeks on a wonderful family vacation to Vietnam and Cambodia.  While it was a mostly psychiatry-free trip, the sign above did grab my attention.  It was a sign at the ecolodge where we were staying in Mai Chau, a rural area of Vietnam where water buffalo are still used as work animals in the rice paddies.  Why are persons with mental illness not permitted in the pool?  I have no idea, but it seems that stigma is rampant everywhere.  So do let me give links to the things I've been...
Source: Shrink Rap - March 1, 2018 Category: Psychiatry Authors: Dinah Source Type: blogs

Will Medical Compliance Ever Become Non-Voluntary?
A recent article by Dr. Lisa Rosenbaum in the New England Journal of Medicine explored both the benefits and drawbacks of Digital Adherence Monitoring. The focus was on the FDA’s recent approval of Abilify MyCite, a medicine technology that combines the medication aripiprazole, used to treat various psychiatric diseases such as schizophrenia, certain features of bipolar disorder and depression, with a digital ingestion tracking system.... // Read More » (Source: blog.bioethics.net)
Source: blog.bioethics.net - January 16, 2018 Category: Medical Ethics Authors: Mark McQuain Tags: Health Care Allocation / Access / Public Health bioethics biotechnology Health Care Practice human dignity syndicated Source Type: blogs

Medgadget ’s Best Medical Technologies of 2017
We reported a surge in the use of augmented reality in healthcare at the end of 2016, with the trend continuing in 2017. Notably, Microsoft’s HoloLens was successfully used for spinal surgery applications by a surgical navigation company named Scopis. There are several advantages to this system including reduced radiation exposure of patients, improved screw placement accuracy, and decreased surgery times. It has been an exciting year for healthcare with many advances in how diseases are diagnosed, treated, and cured. Medical devices are constantly becoming smaller, smarter, cheaper, more precise and user ...
Source: Medgadget - December 26, 2017 Category: Medical Devices Authors: Editors Tags: Exclusive Source Type: blogs

The 10 Most Exciting Digital Health Stories of 2017
Gene-edited human embryo. Self-driving trucks. Practical quantum computers. 2017 has been an exciting year for science, technology – and digital health! It’s that time of the year again when it’s worth looking back at the past months; and list the inventions, methods and milestone events in healthcare to get a clearer picture what will shape medicine for the years to come. 2017 – Amazing year for science and healthcare Scientists, researchers, and innovators come up with amazing breakthroughs every year, and that was no different in 2017 either. No matter whether we look at physics (proving the exis...
Source: The Medical Futurist - December 13, 2017 Category: Information Technology Authors: nora Tags: Future of Medicine 3d printing artificial intelligence digital health genetics genomics Healthcare Innovation Personalized medicine robotics technology wearables Source Type: blogs

A psychiatrist ’s perspective on the digital pill
One of my readers, Natalie, wondered about my thoughts about the digital pill. My initial reactions were similar to several of those who were interviewed for the article. The digital pill, which provides electronic information to confirm whether someone has ingested the medication, has great potential to become a tool of coercion. Aripiprazole (Abilify) is classified as an antipsychotic medication, which is often prescribed to people who have beliefs that machines and other surveillance tools are in their bodies. Why would the nascent technology of a digital pill make its debut for this population? I have se...
Source: Kevin, M.D. - Medical Weblog - December 2, 2017 Category: General Medicine Authors: < a href="https://www.kevinmd.com/blog/post-author/maria-yang" rel="tag" > Maria Yang, MD < /a > Tags: Tech Medications Psychiatry Source Type: blogs

Should You Let Your Doctor Monitor Your Medication Intake?
A new pill has been approved by the U.S. Food & Drug Administration (FDA) that, when swallowed, notifies a monitoring device you wear that you actually took the medication. Sounds invasive and a gross violation of your privacy? Well, it would be. Except for the small problem that every year, millions of people say or agree to take a medication, and then stop taking it when they start to feel better. It’s a long-standing problem for people diagnosed with certain types of mental illness, and leads to serious and significant problems — for the patient, their family, and society as a whole. The new medication ...
Source: World of Psychology - November 18, 2017 Category: Psychiatry & Psychology Authors: John M. Grohol, Psy.D. Tags: Antipsychotic Bipolar Disorders General Medications Schizophrenia Treatment abilify mycite medication sensor medication tracking sensor that you swallow swallable sensor tracking medications Source Type: blogs

Psychology Around the Net: November 18, 2017
This week’s Psychology Around the Net brings you the latest on the Army’s “mental health waiver” plan, FDA-approved medication with a digital ingestion sensor (yum), why you have recurring dreams and how you can control them, and more. Have fun! John McCain Is Threatening Trump’s Defense Nominees Over the Army’s Plan to Offer Mental-Health Waivers: While the Army says its plan to offer waivers for some mental health conditions is just a minor administrative change, Senator John McCain is threatening to slow down the confirmation process if the Pentagon doesn’t provide more thoroug...
Source: World of Psychology - November 18, 2017 Category: Psychiatry & Psychology Authors: Alicia Sparks Tags: Brain and Behavior Children and Teens Dreams Medications Military Personality Psychology Around the Net Research Self-Help Technology Abilify abuse Adult Army Fda image-rehearsal therapy John McCain mental health waivers Source Type: blogs

ABILIFY MYCITE, The First FDA Approved Digital Medicine That Tracks Its Own Ingestion
Proteus Digital Health, a Redwood City firm, and Otsuka Pharmaceutical of Tokyo, Japan won FDA approval for the world’s first digital pill. The ABILIFY MYCITE (aripiprazole) is a tablet with a tiny sensor embedded in its interior. After the tablet is swallowed and dissolved, the sensor meets the stomach juices, which activate it and allow it to communicate with a patch worn by the patient. The patch transmits its readings to a smartphone or tablet, communicating every time that the pill is swallowed with the patients doctor or caretakers. The tiny ingested sensor is then passed by the GI system and leaves the body. T...
Source: Medgadget - November 14, 2017 Category: Medical Devices Authors: Editors Tags: GI Medicine Psychiatry Source Type: blogs

When Paranoia Meets Reality: Your Medicine Snitching On You
Medication non-compliance is a problem: patients don't take their pills.  We hear about it all the time in psychiatry: people don't take their medications and they relapse.  Sometimes they decide they don't need them when they do, sometimes they don't like the side effects or risks of the medications, but mostly, they just forget.  You may hear about this problem as if it belongs to psychiatry, but it doesn't. Patients don't take their cardiac medications, either; in fact humans are only randomly compliant with all types of meds.Swoop in technology, here to solve the problem.  Now sensors placed in...
Source: Shrink Rap - November 14, 2017 Category: Psychiatry Authors: Dinah Source Type: blogs

FDA approves pill with sensor that digitally tracks ingestion
For the past several years, we had heard about the sensor technology and patch developed by Proteus Digital Health. The FDA just approved the first pill that integrates this technology into Abilify, a drug used to treat schizophrenia.Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor embedded in the pill that records that the medication was taken. The product is approved for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and for use as an add-on treatment for depression in adults.FDA announcement. (Source: Medicine and Te...
Source: Medicine and Technology by Dr. Joseph Kim - November 13, 2017 Category: Information Technology Source Type: blogs

Top 25 Psychiatric Medications for 2016
Most people understand that the role of psychiatric medications is to help alleviate the symptoms associated with different types of mental disorders, such as depression, bipolar disorder, ADHD, schizophrenia, anxiety, and more. Psychiatric medications are an important part of a comprehensive treatment plan for effectively treating people who have a mental health concern or mental illness. It’s good to know what drugs are being most-often prescribed for mental disorders in the U.S. These are the top 25 psychiatric medications by number of U.S. prescriptions dispensed in 2016, according to QuintilesIMS, a global infor...
Source: World of Psychology - October 12, 2017 Category: Psychiatry & Psychology Authors: John M. Grohol, Psy.D. Tags: General Medications Psychiatry Treatment medications for mental illness Psychiatric Drugs Psychiatric Medications psychiatric meds top psychiatric medications Source Type: blogs

Hating on Antipsychotics: Are We Going Too Far?
(Source: The Carlat Psychiatry Blog)
Source: The Carlat Psychiatry Blog - September 12, 2017 Category: Psychiatry Tags: antipsychotics aripiprazole bupropion FDA Research Source Type: blogs

Sharing Knowledge of Your Mental Health Issues
We were on Route 9 in between Kremmling and Silverthorne, Colorado. Our ultimate destination was Colorado Springs. To say that we were out in the boonies was an understatement. Mountains rose up to the right and left of us. I was enjoying the solitude when suddenly my cell phone rang. Who could be calling me? It was a New York City area code and a phone number that I didn’t immediately recognize. I was surprised I could even get cell phone service at this altitude. “Hello,” I said. “Laura, it’s Maria. I’m calling your from Switzerland.” (Maria’s husband was from Switzerland, ...
Source: World of Psychology - August 28, 2017 Category: Psychiatry & Psychology Authors: Laura Yeager Tags: Anxiety and Panic Bipolar Medications Peer Support Personal Stigma Bipolar Disorder Helping Others new medication Sharing Wisdom Source Type: blogs

10 Things Every Alzheimer's Caregiver Needs to Know and Discuss with Their Doctor
TheAmerican Geriatrics Society has published a list of ten things doctors and their patients should consider, know and understand.I think it is important forevery caregiver of a person living with Alzheimer's, or a related dementia, todiscuss these 10 issues with the doctor. Doing this in advance might be one of the most important caregiverdecisions you can make.It might also be a good idea toshare this article in support groups, and bookmark (save) it so you can find it when you need it.What is Alzheimer's Disease?By Carole Larkinhttp://www.alzheimersreadingroom.comI think this is an important list of things that nee...
Source: Alzheimer's Reading Room, The - April 13, 2017 Category: Neurology Authors: rtdemarco at gmail.com Tags: alzheimer care care of dementia patients dementia help for caregivers elderly dementia care geriatrics health help alzheimer's help with dementia help with dementia care life news memory care facility Source Type: blogs

Bristol-Myers Squibb Settles Off-Label Promotion Case for $19.5 Million
Late last year, Bristol-Myers Squibb (BMS) settled with the government to resolve allegations that spanned several states that it improperly promoted a schizophrenia treatment for uses not approved by the United States Food and Drug Administration (FDA). The agreement, with a whopping forty-two states (including California, New York, and Texas) and the District of Columbia, focuses on charges that BMS promoted Abilify (an anti-psychotic drug) for use in children and elderly patients with dementia and Alzheimer’s disease. The FDA approved Abilify in 2002 for treating schizophrenic adults. Since then, it has since app...
Source: Policy and Medicine - March 30, 2017 Category: American Health Authors: Thomas Sullivan - Policy & Medicine Writing Staff Source Type: blogs

As US Attorney, Labor Secretary Nominee Enabled Drug and Biotechnology Executives' Impunity
The new Trump administration nominee for US Secretary of Labor is a former US Attorney for the southern district of Florida.  In that role, he seemed to uphold the ideas that certain big corporations, particularly big pharmaceutical and biotechnology corporations, are too big to jail, and that top executives of big corporations should not be held accountable for their corporations'actions.He had central involvement in three bigsettlements of charges of corporate misbehavior which held no individuals accountable for enabling, authorizing, directing or implementing the bad behavior.  The settlements imposed only mo...
Source: Health Care Renewal - February 21, 2017 Category: Health Management Tags: bribery Bristol-Myers-Squibb deception Donald Trump Genzyme GlaxoSmithKline impunity kickbacks legal settlements manipulating clinical research Sanofi-Aventis Source Type: blogs

More Health Care Professionals and Trainees Provoked to Resist - Dana-Farber Cancer Institute Protest of Leaders' Acquiescence to Trump's Muslim Travel Ban
The executive order by President Trump that temporarily banned immigration from seven predominantly Muslim countries provoked health care professionals and trainees to challenge another health care leader whom had not been so challenged previously.We recently described how professionals and trainees protested the decision by Cleveland Clinic CEO Toby Cosgrove not to cancel a fund raising event a Mar a Lago, the resort owned by President Trump, even though Mr Trump's ban had resulted in the deportation (since reversed) of a Cleveland Clinic physician trainee, and Cleveland Clinic health care professionals and trainees had c...
Source: Health Care Renewal - February 9, 2017 Category: Health Management Tags: anechoic effect boards of directors Bristol-Myers-Squibb conflicts of interest Donald Trump Harvard Medical School logical fallacies Source Type: blogs

Medications that Increase the Risks of Falling
Falls are the leading cause of both fatal and non-fatal injuries for adults 65 and older, and research suggests that those taking four or more medications are at an even greater risk than those who don ’t.ByAlzheimer's Reading RoomWhat ’s the Difference Between Alzheimer’s and DementiaHow to Test Your Memory for Alzheimer's and DementiaHow to Get Answers To Your Questions About Alzheimer's and Dementia“Falls are the leading cause of both fatal and non-fatal injuries for adults 65 and older, and research suggests that those taking four or more medications are at an even greater risk than those who do...
Source: Alzheimer's Reading Room, The - February 1, 2017 Category: Neurology Tags: alzheimer's care care of dementia patients dementia care health help alzheimer's help with dementia care medications falls Prescription Medications Risks risk of falling senior care Source Type: blogs

Updated Medicare and Medicaid Drug Spending Data Released
On November 15, 2016, the Centers for Medicare and Medicaid Services (CMS) released updated Medicare and Medicaid drug spending data, to include information for calendar year (CY) 2015 through its online interactive dashboards for Medicare and Medicaid. The inclusion of the Medicaid drug spending data on the public dashboard is new this year, as is the addition of high-level (aggregated) Medicare drug rebate data. CMS noted that “there is significant growth in spending on prescription drugs, representing a significant burden.” In CY 2015, total prescription drug costs amounted to roughly $457 billion – a...
Source: Policy and Medicine - December 15, 2016 Category: American Health Authors: Thomas Sullivan - Policy & Medicine Writing Staff Source Type: blogs

Study: For good and bad, TV ads promote higher prescribing volume of psychiatric medications
Conclusions: Findings suggest that DTCA requests are typically accommodated, promote higher prescribing volume, and have competing effects on treatment quality. More methodologically strong studies are needed to increase confidence in conclusions. Related articles: Systematic evidence review finds cognitive behavioral therapy as effective as antidepressant medicines in treating depression Next: Harnessing information and communications technology (ICT) to address mental health challenges affecting 700 million people today (Source: SharpBrains)
Source: SharpBrains - November 11, 2016 Category: Neuroscience Authors: SharpBrains Tags: Cognitive Neuroscience Health & Wellness anti-depressants bipolar depression FDA medications Mental-Health prescription prescription medications psychiatric medications psychiatry public-health Source Type: blogs

Dementia Care, Which Drugs Increase the Risk of Falling
Medications can increase the risk of falls and falling; and, are a major cause of injuries and death in older adults.By Bob DeMarcoAlzheimer's Reading RoomDuring the entire 8 and a half years, 3,112 days, that I was taking care of my mother, I worried about her falling.Falls can result in hip injuries, head injuries, or something worse.If you loved one is falling, or complaining of "dizziness" check out the list of medications below; and then, consult with your personal care doctor.Problems with Balance, Walking, Falling an Early Sign of DementiaThe drugs older people take can make them more susceptible to fallin...
Source: Alzheimer's Reading Room, The - September 7, 2016 Category: Neurology Tags: alzheimer's care Alzheimer's Dementia dementia care dementia falls dementia help for caregivers family caregiving help alzheimer's help with dementia care memory care searches related to falling Source Type: blogs

CMS Releases New Prescription Drug Cost Data
On August 18, 2016, the Centers for Medicare and Medicaid Services (CMS) released new prescription drug data, physician-level data on prescriptions for drugs paid for by Medicare Part D in 2014. This new data set “describes the specific medications prescribed for 38 million Medicare Part D enrollees, who represent about 70 percent of all Medicare beneficiaries.” This is the second annual release of the data. According to Niall Brennan, CMS Chief Data Officer, “With this data release, patients, researchers and providers can access valuable information about the Medicare prescription drug program. Today&rs...
Source: Policy and Medicine - September 2, 2016 Category: American Health Authors: Thomas Sullivan - Policy & Medicine Writing Staff Source Type: blogs

Dear Boston Globe Spotlight Team: Access to Care is About So Much More than Public Safety
The Boston Globe Spotlight Team -- the investigative reporting team featured in the Oscar-winning, best pictureSpotlight -- is doing a six-part series on the shambles the mental health system has become in Massachusetts.  And make no mistake, their system is a shambles.  The series is called The Desperate and the Dead, and while I understand that journalism involves sensationalism to get people to read, the emphasis on violence in these articles is striking, and unnecessarily provocative.  It's stigmatizing and distracts from the real issues.  This from an author who has abook coming out shortly about p...
Source: Shrink Rap - August 28, 2016 Category: Psychiatry Authors: Dinah Source Type: blogs

Ode to the Duke
I saw my shrink today. I call him “The Duke.” We had a perfectly fine half-hour meeting. He wrote me some scripts and listened to my current take on my life. Mainly, we talked about my son Tommy’s fear of entering sixth grade. The Duke warned me that the junior high years are awful and to brace myself. The Duke is a straight shooter. At the end of the appointment, I asked him how he thought I was doing. “Fine,” he said. “You’re doing fine.” “I think I’ve licked bipolar illness,” I said. “Don’t say that,” he replied quickly. Perha...
Source: World of Psychology - August 19, 2016 Category: Psychiatry & Psychology Authors: Laura Yeager Tags: Bipolar Caregivers Disorders General Personal Psychiatry Treatment Bipolar Disorder Love Medicine Patient Sigmund Freud St. Dymphna Source Type: blogs

Law and Order? - Bristol-Myers-Squibb Settles Case Alleging Fraud and Kickbacks, No Admissions of Guilt, No Individuals Charged
Introduction &nbsp; Donald Trump, Republican candidate for the US presidency last week announced he is the " law and order " candidate, accompanied by then vice presidential contender and New Jersey Governor Chris Christie. I wonder if all this interest in law and order will lead to increasing the effectiveness of enforcing laws when large US health care corporations are accused? For years, we have been watching a parade of legal settlements made by big US health care organizations. &nbsp; These have included the biggest drug companies, biotechnology companies, device companies, insurance companies,...
Source: Health Care Renewal - July 21, 2016 Category: Health Management Tags: Abilify Bristol-Myers-Squibb crime impunity kickbacks legal settlements logical fallacies Source Type: blogs

The Rigid Patient
​A 24-year-old man with a history of schizophrenia presented with altered mental status. His mother said he had become more catatonic and rigid over the previous two days. She reported that he was prescribed Abilify 5 mg by mouth daily for three years, but a long-acting depot of Abilify 400 mg had been administered two days before by court order. His vital signs include a heart rate of 120 bpm, blood pressure 140/90 mm Hg, temperature 38.5°C, respiratory rate is 14 bpm, and SPO2 is 98% on room air. The patient is alert and diaphoretic. Pupils are 3 mm. Cogwheeling, rigidity, and two beats of ankle clonus are als...
Source: The Tox Cave - June 2, 2016 Category: Emergency Medicine Tags: Blog Posts Source Type: blogs

A Year in Review: FDA 2015 New Drug Approvals
The approval of first-of-a-kind drugs rose last year to forty-one, resulting in the highest level of newly approved U.S. drugs in nineteen years. The total number of new drugs approved last year was even higher at sixty-nine. The rising figures reflect an industry-wide desire to research and develop drugs for rare and hard-to-treat diseases. The newly approved drugs serve to advance medical care and the health of patients suffering from many ailments, including various forms of cancer, heart failure, and cystic fibrosis. Additionally, more than 40% of the new therapies were approved for treatment of rare or "orphan&...
Source: Policy and Medicine - January 13, 2016 Category: American Health Authors: Thomas Sullivan - Policy & Medicine Writing Staff Source Type: blogs

FDA Approves New Drug Vraylar
A new antipsychotic drug that can be used to treat schizophrenia and bipolar disorder in adults has been approved by the FDA. Vraylar belongs to a class of drugs known as atypical antipsychotics. Others in this group include Abilify (aripiprazole), Seroquel (quetiapine) and Risperdal (risperidone). (Source: Weird Cake: Myopic musings from a bipolar survivor)
Source: Weird Cake: Myopic musings from a bipolar survivor - September 29, 2015 Category: Psychiatry Source Type: blogs

FDA OPDP Issues Fifth Letter of Caution for the Year, Cites Oak Pharmaceuticals For Exhibit Banner
Almost like clockwork, the Food and Drug Administration’s Office of Prescription Drug Promotion (OPDP) has released its fifth enforcement letter of 2015—they have issued one letter in January, February, March, April, and now, as of the past week, one in May. OPDP sent the Untitled Letter to Oak Pharmaceuticals, Inc. (a subsidiary of Akorn, Inc.) regarding the company’s barbiturate anticonvulsant, Nembutal. View the promotional material here. The agency found that Oak’s table exhibit banner was misleading because it omitted “important risk information associated with the use of Nembutal,”...
Source: Policy and Medicine - May 21, 2015 Category: American Health Authors: Thomas Sullivan Source Type: blogs

Judge Dismisses Off-Label and Kickback Allegations Against Bristol-Myers Squibb, But BMS Must Face Whistleblower Retaliation Suit
District Court Judge William Bertelsman recently dismissed False Claims Act (FCA) allegations against Bristol-Myers Squibb and Otsuka Pharmaceuticals brought by two former BMS sales reps. Despite finding the whistleblowers failed to show that the company engaged in either off-label promotion or kickbacks in violation of the FCA, however, Judge Bertelsman held that the whistleblowers adequately pled wrongful retaliation claims. According to the former sales reps, they tried to bring their compliance concerns up the company chain, but were instead punished with poor performance reviews. Both employees were terminated so...
Source: Policy and Medicine - April 1, 2015 Category: American Health Authors: Thomas Sullivan Source Type: blogs

What does it mean to live in the age of Abilify? 
I learned recently that the antipsychotic Abilify is the biggest selling prescription drug in the U.S.  To be a top seller, a drug has to be expensive and also widely used.  Abilify is both.  It’s the 14th most prescribed brand-name medication, and it retails for about $30 a pill.  Annual sales are over $7 billion, nearly a billion more than the next runner-up. Continue reading ... Your patients are rating you online: How to respond. Manage your online reputation: A social media guide. Find out how. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - March 23, 2015 Category: Journals (General) Authors: Tags: Meds Medications Psychiatry Source Type: blogs

Abilify: It's Really Expensive!
Sometimes, I like to bother pharmacists.  They are the nicest people, and very patient about looking up medication costs for me.  Once, I wrote a post called The Co$t of Being Depressed, where I compared the cost of anti-depressants. Today,  I'm writing over on our Clinical Psychiatry News website about The Surprisingly High Cost of Abilify.  Here's the short form, but do surf over there for details:I called three pharmacies and compared prices on Abilify.Please remember, this data is for three pharmacies only A single 2 mg tablet cost between $30 and $33 dollars.  More don't cost appreciably less ...
Source: Shrink Rap - November 14, 2014 Category: Psychiatrists and Psychologists Authors: Dinah Source Type: blogs

A patient’s experience with diagnostic overshadowing
I have been a victim of diagnostic overshadowing by a primary care physician.  I’ve been dealing with major depressive disorder, recurrent, severe and anorexia for twenty-five years — practically my entire adult life.  However, I work full-time and I’m a published writer.  At the time I saw this PCP, I was on hefty doses of Cymbalta (an antidepressant) and Abilify (an antipsychotic which can also be used to boost the effects of an antidepressant). Continue reading ... Your patients are rating you online: How to respond. Manage your online reputation: A social media guide. Fi...
Source: Kevin, M.D. - Medical Weblog - November 4, 2014 Category: Journals (General) Authors: Tags: Patient Pain management Patients Primary care Source Type: blogs

Clever Hospitals Find Another Way to Snag New Patients
Last month, I wrote about a hospital system in Colorado that had discovered a way to cross market its more profitable emergency room services if a patient first came to its urgent care center. Pretty clever! Then recently I came across another health care marketing trick close to home and just as sly. As I sat on a New York subway one sizzler of a day, an ad for an ice cream cone grabbed my attention. Ice cream! Hot day! After a closer read, I realized the ad was not touting ice cream but the Center for Advanced Digestive Care, a part of New York Presbyterian, one of the city’s most prestigious hospitals and well kno...
Source: Disruptive Women in Health Care - August 19, 2014 Category: Consumer Health News Authors: dw at disruptivewomen.net Tags: Uncategorized Source Type: blogs

What’s In Our Medicine Cabinets?
By HANS DEUVEFELT, MD  Recently published statistics show that the top-grossing medication in the U.S. for 2013 was the antipsychotic Abilify (aripiprazole) with over $6 billion in sales, narrowly beating out the previous few years’ winner, Nexium. The past decade’s dominating pharmaceuticals have been Lipitor (atorvastatin) for high cholesterol and Nexium (esomeprazole) for acid reflux. Nexium […] (Source: The Health Care Blog)
Source: The Health Care Blog - June 20, 2014 Category: Consumer Health News Tags: THCB Abilify Drug sales Medicalization Nexium Pharmaceutical sales Viagra Source Type: blogs

Cardiovascular and Diabetes Outcomes Among Those taking Novel Antipsychotics
I remember from medical school and the early days of my residency when the only medications available to treat psychosis were the neuroleptics.  Patients hated taking them: the high potency medicines like Haldol and Prolixin left people rigid; they had pill-rolling movements with their fingers, cogwheeling in their joints, and they walked liked zombies.  The lower potency medications like Mellaril left people drooling and sedated.  I once heard these medications described as like having molasses poured into your brain.  We'd cajole people in to taking them, and like all medications, there were some peop...
Source: Shrink Rap - January 20, 2014 Category: Psychiatrists and Psychologists Authors: Dinah Source Type: blogs

Results of the Survey on Who Are the Mentally Ill?
Thank you to everyone who participated!The survey was published on Shrink Rap from December 10, 2013 - December 22, 2013.Respondents were solicited through social media, including blogs, listservs, Facebook, and Twitter.  Respondents were not limited to the United States.  Please note that the survey was not validated.  The data below was pasted directly from the Google "Summary of Responses" with no analysis or interpretation.SummaryAnyone who has seen a therapist is mentally illTrue172%False67698%Anyone who has been in psychotherapy with a psychiatrist is mentally illTrue619%False63091%Anyon...
Source: Shrink Rap - January 2, 2014 Category: Psychiatrists and Psychologists Authors: Dinah Source Type: blogs

A Guide To: Abilify
Abilify has quickly become one of the top prescription medications in the United States. This guide offers beginner information about the antipsychotic drug.Contributor: Nicole M.Published: Nov 03, 2013 (Source: Most Recent Health Wellness - Associated Content)
Source: Most Recent Health Wellness - Associated Content - November 3, 2013 Category: Other Conditions Source Type: blogs

Antipsychotics Can Triple The Risk That Children Develop Diabetes
In a disturbing finding, children prescribed several widely prescribed antipsychotics face a threefold risk of developing type 2 diabetes within the first year of usage compared with other medications that are available for the same disorders the medicines are used to treat. Originally prescribed for schizophrenia, the pills are now used to treat bipolar disorder, ADHD and mood disorders, such as depression. “It’s well known that antipsychotics cause diabetes in adults, but until now the question hadn’t been fully investigated in children,: Wayne Ray, one of the study authors and director of the division ...
Source: Pharmalot - August 22, 2013 Category: Pharma Commentators Authors: esilverman Source Type: blogs

Over-Drugged Medicaid Children
As reported in the Wall Street Journal (here):"Federal health officials have launched a probe into the use of antipsychotic drugs on children in the Medicaid system, amid concern that the medications are being prescribed too often to treat behavioral problems in the very young.  "The effort applies to a newer class of antipsychotic drugs known as "atypicals," which include Abilify, the nation's No. 1 prescription drug by sales. The drugs were originally developed to treat psychoses such as schizophrenia, but some now have Food and Drug Administration approval for treatment of children with con...
Source: Pharma Marketing Blog - August 13, 2013 Category: Pharma Commentators Tags: Cymbalta Seroquel medicaid anti-psychotics Children Abilify Source Type: blogs

Feds Probe Antipsychotic Prescriptions For Children In Medicaid
In response to the rising rate at which antipsychotics are prescribed to children, the Office of Inspector General at the US Department of Health & Human Services is investigating the trend and asked the states to tighten prescribing oversight, The Wall Street Journal writes. The move comes amid ongoing that the drugs are used too freely to children to curb violent or aggressive behavior. The issue, in fact, has been contentious for several years, especially before drugmakers won FDA approval to market their antipsychotics, which are approved to treat schizophrenia, bipolar disorder and autistic disorder, to increasing...
Source: Pharmalot - August 12, 2013 Category: Pharma Commentators Authors: esilverman Source Type: blogs

At Last! - U.S. Probes Use of Antipsychotic Drugs on Children
By LUCETTE LAGNADO Federal health officials have launched a probe into the use of antipsychotic drugs on children in the Medicaid system, amid concern that the medications are being prescribed too often to treat behavioral problems in the very young. The inspector general's office at Department of Health and Human Services says it recently began a review of antipsychotic-drug use by Medicaid recipients age 17 and under. And various agencies within HHS are requiring officials in all 50 states to tighten oversight of prescriptions for such drugs to Medicaid-eligible young people. View Graphics The effort applies to a newe...
Source: PharmaGossip - August 12, 2013 Category: Pharma Commentators Authors: insider Source Type: blogs

Breakthroughs in Bipolar Treatment
"We should continue to repurpose treatments and to recognise the role of serendipity" (Geddes & Miklowitz, 2013).That quote was from a recent review article in The Lancet, which did not hint at any impending pharmacological breakthroughs in the treatment of bipolar disorder. In other words, the future of bipolar treatment doesn't look much different from the present (at least in the immediate term). Bipolar disorder, an illness defined by the existence of manic or hypomanic highs, alternating with depressive lows, can be especially difficult to treat. And the mood episode known as a mixed state, where irritab...
Source: The Neurocritic - August 2, 2013 Category: Psychiatrists and Psychologists Authors: The Neurocritic Source Type: blogs

OCD & Chinatown
One way to explain obsessive-compulsive disorder involves a comparison to the old Roman Polanski film “Chinatown”, starring Jack Nicholson. Nicholson plays a detective investigating a suspicious California land developer (played by the director John Huston). As in many detective thrillers, the closer he gets to the truth, the more chaos ensues. He uncovers an incestuous relationship, innocent characters are murdered, and in the final scene, his friend declares his efforts to make the situation right a lost cause, a tragedy (“It’s Chinatown, Jake”). Thankfully, I don’t view obsessive-comp...
Source: World of Psychology - July 22, 2013 Category: Psychiatrists and Psychologists Authors: Keith Fraser Tags: Brain and Behavior Disorders General Industrial and Workplace Mental Health and Wellness Money and Financial OCD Personal Treatment Academic Achievement California Land Chinatown Director John Huston Film Of The Same Name Great Source Type: blogs